Search

UT Southwestern Medical Center has been selected to operate the new Texas Behavioral Health Center – the first state acute care behavioral health hospital in the Dallas-Fort Worth area – announcing plans to care for its first patients this summer.

UT Southwestern Communications tells stories about the extraordinary work being done here every day and about the dedicated, passionate people behind it. Explore these stories.

The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern earned exemplary marks as part of the renewal of its comprehensive designation by the National Cancer Institute (NCI).

Russell DeBose-Boyd, Ph.D., Professor of Molecular Genetics at UT Southwestern Medical Center, has been awarded the Hill Prize in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) in recognition of his long-standing research into a key mechanism

Vincent Tagliabracci, Ph.D., Associate Professor of Molecular Biology at UT Southwestern Medical Center, will receive the 2024 Edith and Peter O’Donnell Award in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) for broadening the understanding of

A program that asks patients to mail in stool samples to screen for colon cancer is an effective way to expand screenings to underserved and underinsured communities and offers an alternative to in-person testing during the pandemic, according to a study conducted by UT Southwestern.

James J. Collins III, Ph.D., Associate Professor of Pharmacology at UT Southwestern Medical Center who leads groundbreaking research into the parasitic disease schistosomiasis, has been named a Howard Hughes Medical Institute (HHMI) Investigator.

David Mangelsdorf, Ph.D., Chair and Professor of Pharmacology and Professor of Biochemistry at UT Southwestern Medical Center, has been awarded the Hill Prize in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) in recognition of his long-standing

Gerta Hoxhaj, Ph.D., Assistant Professor in Children’s Medical Center Research Institute at UT Southwestern (CRI), is the recipient of the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) 2025 Mary Beth Maddox Award and Lectureship for her research in cancer metabolism.

Overweight and obesity patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs were more likely to stick with their treatment longer than those who didn’t switch, according to a new study by UT Southwestern Medical Center researchers.